Fabienne Guillaumond

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersSolid tumoursPeripheral nervous systemCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Celia Sequera, Margherita Grattarola, Floriane Cannet

|Apr 14, 2022
Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer.

Jérémy Guillot, Chloé Dominici, Adrien Lucchesi

|Mar 21, 2022
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.

Victoire Gouirand, Tristan Gicquel, Evan C Lien

|Aug 20, 2021
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma.

Angélina Acier, Magali Godard, Fanny Gassiot

|Jun 02, 2021
Distinction between 2'- and 3'-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration.

Raoul Manuel, Michelle de Souza Lima, Sébastien Dilly

Pageof 1